A Blend of Phellodendron and Crape Myrtle Improves Glucose Tolerance in Exercise-trained Men

Overview

Journal Nutr Metab Insights

Publisher Sage Publications

Specialty Endocrinology

Date 2013 Aug 16

PMID 23946660

Authors

Robert E Canale

Tyler M Farney

Cameron G McCarthy

Richard J Bloomer

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to investigate the acute effects of a nutritional supplement containing a proprietary blend of Phellodendron and Crape Myrtle on serum glucose and insulin in response to a modified oral glucose tolerance test (OGTT).

Methods: Using a randomized, double-blind, cross-over design, 10 exercise-trained, non-diabetic men reported to the lab in a 10 hour fasted state, on two different mornings separated by 1-2 weeks, and were subjected to an OGTT by ingesting a 75 gram dextrose solution. Fifteen minutes prior to the OGTT subjects ingested either a dietary supplement containing a blend of Phellodendron and Crape Myrtle (SUPP) or a placebo (PLA). Blood samples were collected before ingestion of the SUPP or PLA and at 15, 30, 45, 60, and 75 minutes post-ingestion of the dextrose load. Samples were analyzed for serum glucose and insulin.

Results: In relation to serum glucose, a condition effect was noted (P = 0.01), with values lower for SUPP compared to PLA. In relation to serum insulin, a trend for a condition effect was noted (P = 0.06), with values lower for SUPP compared to PLA.

Conclusion: These findings indicate that acute ingestion of a dietary supplement containing a blend of Phellodendron and Crape Myrtle can lower the serum glucose response to a modified OGTT, while resulting in a non-significant attenuation in insulin response. These data are specific to a small sample of exercise-trained, non-diabetic men.

References

Liu F, Kim J, Li Y, Liu X, Li J, Chen X . An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr. 2001; 131(9):2242-7. DOI: 10.1093/jn/131.9.2242. View

Praet S, van Loon L . Optimizing the therapeutic benefits of exercise in Type 2 diabetes. J Appl Physiol (1985). 2007; 103(4):1113-20. DOI: 10.1152/japplphysiol.00566.2007. View

Miura T, Ueda N, Yamada K, Fukushima M, Ishida T, Kaneko T . Antidiabetic effects of corosolic acid in KK-Ay diabetic mice. Biol Pharm Bull. 2006; 29(3):585-7. DOI: 10.1248/bpb.29.585. View

Bartlett H, Eperjesi F . Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008; 28(6):503-23. DOI: 10.1111/j.1475-1313.2008.00595.x. View

Yamada K, Hosokawa M, Fujimoto S, Fujiwara H, Fujita Y, Harada N . Effect of corosolic acid on gluconeogenesis in rat liver. Diabetes Res Clin Pract. 2008; 80(1):48-55. DOI: 10.1016/j.diabres.2007.11.011. View

Ni Y . [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research]. Zhong Xi Yi Jie He Za Zhi. 1988; 8(12):711-3, 707. View

Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G . Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007; 56(3):405-12. DOI: 10.1016/j.metabol.2006.10.025. View

Zhang H, Wei J, Xue R, Wu J, Zhao W, Wang Z . Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2009; 59(2):285-92. DOI: 10.1016/j.metabol.2009.07.029. View

Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B . Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002; 106(10):1211-8. DOI: 10.1161/01.cir.0000027569.76671.a8. View

10.

Judy W, Hari S, Stogsdill W, Judy J, Naguib Y, Passwater R . Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study. J Ethnopharmacol. 2003; 87(1):115-7. DOI: 10.1016/s0378-8741(03)00122-3. View

11.

Shi L, Zhang W, Zhou Y, Zhang Y, Li J, Hu L . Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol. 2008; 584(1):21-9. DOI: 10.1016/j.ejphar.2008.01.020. View

12.

Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N . Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008; 93(7):2559-65. DOI: 10.1210/jc.2007-2404. View

13.

Lee I, Kim H, Bae J . Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract Suppl. 2002; (129):59-64. View

14.

Nahas R, Moher M . Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician. 2009; 55(6):591-6. PMC: 2694078. View

15.

Bloomer R, Kabir M, Marshall K, Canale R, Farney T . Postprandial oxidative stress in response to dextrose and lipid meals of differing size. Lipids Health Dis. 2010; 9:79. PMC: 2915990. DOI: 10.1186/1476-511X-9-79. View

16.

Fonseca V, Zinman B, Nauck M, Goldfine A, Plutzky J . Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med. 2010; 123(7):S2-S10. DOI: 10.1016/j.amjmed.2010.04.002. View

17.

Miura T, Itoh Y, Kaneko T, Ueda N, Ishida T, Fukushima M . Corosolic acid induces GLUT4 translocation in genetically type 2 diabetic mice. Biol Pharm Bull. 2004; 27(7):1103-5. DOI: 10.1248/bpb.27.1103. View

18.

Pruessner J, Kirschbaum C, Meinlschmid G, Hellhammer D . Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003; 28(7):916-31. DOI: 10.1016/s0306-4530(02)00108-7. View

19.

Kulkarni S, Dhir A . Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 2009; 24(3):317-24. DOI: 10.1002/ptr.2968. View

20.

Kong W, Zhang H, Song D, Xue R, Zhao W, Wei J . Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2008; 58(1):109-19. DOI: 10.1016/j.metabol.2008.08.013. View